Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

48 trials with published results (6%)

Research Maturity

388 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.7%

54 terminated out of 805 trials

Success Rate

87.8%

+1.3% vs benchmark

Late-Stage Pipeline

18%

147 trials in Phase 3/4

Results Transparency

12%

48 of 388 completed with results

Key Signals

48 with results88% success54 terminated

Data Visualizations

Phase Distribution

505Total
Not Applicable (225)
Early P 1 (2)
P 1 (31)
P 2 (100)
P 3 (78)
P 4 (69)

Trial Status

Completed388
Unknown177
Recruiting94
Terminated54
Not Yet Recruiting51
Withdrawn21

Trial Success Rate

87.8%

Benchmark: 86.5%

Based on 388 completed trials

Clinical Trials (805)

Showing 20 of 20 trials
NCT03334006Phase 2Recruiting

Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis

NCT05900284Phase 2Completed

Safety and Feasibility of Metformin for Sepsis Induced AKI

NCT07630415Not Yet Recruiting

EARLY DIAGNOSIS OF SEPTIC DIC

NCT07628023Not Yet RecruitingPrimary

Comparison of Cardiac Index Measurement Using Right Ventricular Pressure Curve Analysis and Thermodilution Via a Swan-Ganz IQ™ Catheter.

NCT06746753Phase 4Not Yet RecruitingPrimary

Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock

NCT07451886Phase 2Recruiting

Adjunctive Fludrocortisone in Septic Shock

NCT07530146Phase 3Recruiting

Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation

NCT07616817Enrolling By InvitationPrimary

Delphi Septic Shock: Sub-phenotypes Using Point-of-Care Ultrasound in Patients With Septic Shock

NCT06692036Not ApplicableEnrolling By InvitationPrimary

Adaptive Blood Purification for the Treatment of Patients With Septic Shock

NCT02361528Phase 3CompletedPrimary

GM-CSF to Decrease ICU Acquired Infections

NCT03783091Phase 2CompletedPrimary

A Trial of Vitamin B12 in Septic Shock

NCT04690530WithdrawnPrimary

Cerebral Hemodynamics and Oxygenation in Critically Ill Patients

NCT07603024Not ApplicableNot Yet RecruitingPrimary

Effect of Shenfu Injection on the Vascular Waterfall Phenomenon in Patients With Septic Shock

NCT06990295Not ApplicableRecruitingPrimary

Focused Ultrasound Spleen Stimulation and Inflammation in Septic Shock

NCT07582926Recruiting

Cortisol Levels and Mortality in Septic Shock ICU Patients

NCT03861325CompletedPrimary

Acute Intestinal Failure in Critically Ill Patients and Microbial Translocation

NCT07585942Not Yet Recruiting

Fluorescent Leukocytes as a Marker of Early Sepsis/Severity

NCT07492030Not Yet Recruiting

Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions

NCT05194189Phase 2Completed

Clinical Efficacy of Megadose Vitamin C in Sepsis

NCT05296590Active Not Recruiting

Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia

Scroll to load more

Research Network

Activity Timeline